Personal information

Activities

Collapse all

Employment (1)

CIC bioGUNE: Derio, ES

Postdoctoral researcher (Cancer Immunology and Immunotherapy Lab)
Employment
Source: Self-asserted source
Ana Garcia

Education and qualifications (4)

Universidad de Valladolid: Valladolid, Castilla y León, ES

2014 to 2019 | PhD candidate
Qualification
Source: Self-asserted source
Ana Garcia

Harvard Medical School: Boston, MA, US

2017 to 2017 | PhD fellow
Education
Source: Self-asserted source
Ana Garcia

Universidad de Valladolid: Valladolid, Castilla y León, ES

2013 to 2014 | Master Degree
Education
Source: Self-asserted source
Ana Garcia

Universidad de Salamanca: Salamanca, Castilla y León, ES

2009 to 2013 | BsC
Qualification
Source: Self-asserted source
Ana Garcia

Professional activities (1)

Universidad de Valladolid: Valladolid, Castilla y León, ES

2013 to 2019
Invited position
Source: Self-asserted source
Ana Garcia

Funding (1)

Bikaintek

Contract
Bikaintek (Basque government, ES)
Source: Self-asserted source
Ana Garcia

Works (11)

SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

Cell Reports
2024-03 | Journal article
DOI: 10.1016/j.celrep.2024.113924
Contributors: Sofia Lachiondo-Ortega; Claudia M. Rejano-Gordillo; Jorge Simon; Fernando Lopitz-Otsoa; Teresa C. Delgado; Krystyna Mazan-Mamczarz; Naroa Goikoetxea-Usandizaga; L. Estefanía Zapata-Pavas; Ana García-del Río; Pietro Guerra et al.
Source: Self-asserted source
Ana Garcia

Factor-inhibiting HIF (FIH) promotes lung cancer progression

JCI Insight
2023-10-23 | Journal article
DOI: 10.1172/jci.insight.167394
Part of ISSN: 2379-3708
Contributors: Ana García-del Río; Endika Prieto-Fernández; Leire Egia-Mendikute; Asier Antoñana-Vildosola; Borja Jimenez-Lasheras; So Young Lee; Adrián Barreira-Manrique; Samanta Romina Zanetti; Ander de Blas; Paloma Velasco-Beltrán et al.
Source: Self-asserted source
Ana Garcia

A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants.

Frontiers in immunology
2022-11-24 | Journal article
DOI: 10.3389/fimmu.2022.1014309
PMID: 36505411
Contributors: Egia-Mendikute L; Bosch A; Prieto-Fernández E; Vila-Vecilla L; Zanetti SR; Lee SY; Jiménez-Lasheras B; García Del Río A; Antoñana-Vildosola A; de Blas A et al.
Source: Self-asserted source
Ana Garcia

Postoperative vitamin and mineral supplementation

Nutrition and Bariatric Surgery
2020 | Book chapter
Source: Self-asserted source
Ana Garcia

Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment

Frontiers in Immunology
2020-09-30 | Journal article
DOI: 10.3389/fimmu.2020.586977
Part of ISSN: 1664-3224
Source: Self-asserted source
Ana Garcia

Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals

Communications Biology
2020-07-29 | Journal article
DOI: 10.1101/2020.07.28.20162941
Source: Self-asserted source
Ana Garcia
grade
Preferred source (of 2)‎

The Mitochondrial Isoform of FASTK Modulates Nonopsonic Phagocytosis of Bacteria by Macrophages via Regulation of Respiratory Complex I

The Journal of Immunology
2018-11-15 | Journal article
DOI: 10.4049/jimmunol.1701075
Part of ISSN: 0022-1767
Part of ISSN: 1550-6606
Source: Self-asserted source
Ana Garcia

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization

Nature Cell Biology
2018-09 | Journal article
DOI: 10.1038/s41556-018-0173-5
Part of ISSN: 1465-7392
Part of ISSN: 1476-4679
Source: Self-asserted source
Ana Garcia

Generation of HeLa knock-out of Fas-activated serine/threonine kinase (FASTK) by CRISPR/Cas9 nickase-mediated homology direct repair.

Mary Ann Liebert, INC.
2016 | Journal article
Source: Self-asserted source
Ana Garcia

Is hydration enough in a healthy group of the elderly in a Valladolid neighbourhood?

NUTRICION HOSPITALARIA
2015-12-02 | Journal article
DOI: 10.3305/nh.2015.32.sup2.10284
Source: Self-asserted source
Ana Garcia

Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate

Emerging Microbes & Infections
Journal article
Source: Self-asserted source
Ana Garcia
How many people are using ORCID?